Sarah Krüg, CEO of CANCER101, a patient advocacy organization. She has been on the board for three years, in a quest to help patients and caregivers navigate the cancer journey. She is also President of the Society for Participatory Medicine, a patient/provider member driven organization whose mission is to enable collaborative partnerships between patients and healthcare professionals. She serves on the board of the Cancer Patient Education Network, an organization created by NCI over 25 years ago to provide a framework for patient educators across institutions worldwide. She also serves on the board of the National Organization of Rare Diseases.
She previously held the position of Global Education Director in the Medical Education Group at Pfizer, focused on establishing global health care improvement strategies and medical education standards worldwide. She also established the Global Investigator Initiated Research Program at Pfizer. Prior to joining Pfizer, Sarah spearheaded the development of the Pediatric Disease Management clinical pathways and conducted clinical research at Memorial Sloan- Kettering Cancer Center.
In her spare time, Sarah enjoys writing and is contributing writer for Pharmaceutical Executive. She is also in the midst of completing two books.